Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia

Randy J. Chandler, Suma Chandrasekaran, Nuria Carrillo-Carrasco, Julien S. Senac, Sean E. Hofherr, Michael A Barry, Charles P. Venditti

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Propionic acidemia (PA) is an autosomal recessive disorder of metabolism caused by a deficiency of propionyl-coenzyme A carboxylase (PCC). Despite optimal dietary and cofactor therapy, PA patients still suffer from lethal metabolic instability and experience multisystemic complications. A murine model of PA (Pcca -/-) of animals that uniformly die within the first 48hr of life was used to determine the efficacy of adeno-associated viral (AAV) gene transfer as a potential therapy for PA. An AAV serotype 8 (AAV8) vector was engineered to express the human PCCA cDNA and delivered to newborn mice via an intrahepatic injection. Greater than 64% of the Pcca -/- mice were rescued after AAV8-mediated gene transfer and survived until day of life 16 or beyond. Western analysis of liver extracts showed that PCC was completely absent from Pcca -/- mice but was restored to greater than wild-type levels after AAV gene therapy. The treated Pcca -/- mice also exhibited markedly reduced plasma levels of 2-methylcitrate compared with the untreated Pcca -/- mice, which indicates significant PCC enzymatic activity was provided by gene transfer. At the time of this report, the oldest treated Pcca -/- mice are over 6 months of age. In summary, AAV gene delivery of PCCA effectively rescues Pcca -/- mice from neonatal lethality and substantially ameliorates metabolic markers of the disease. These experiments demonstrate a gene transfer approach using AAV8 that might be used as a treatment for PA, a devastating and often lethal disorder desperately in need of new therapeutic options.

Original languageEnglish (US)
Pages (from-to)477-481
Number of pages5
JournalHuman Gene Therapy
Volume22
Issue number4
DOIs
StatePublished - Apr 1 2011

Fingerprint

Propionic Acidemia
Dependovirus
Methylmalonyl-CoA Decarboxylase
Viral Genes
Genes
Liver Extracts
Metabolic Diseases
Therapeutics
Serogroup
Genetic Therapy
Animal Models
Complementary DNA
Injections

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Chandler, R. J., Chandrasekaran, S., Carrillo-Carrasco, N., Senac, J. S., Hofherr, S. E., Barry, M. A., & Venditti, C. P. (2011). Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia. Human Gene Therapy, 22(4), 477-481. https://doi.org/10.1089/hum.2010.164

Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia. / Chandler, Randy J.; Chandrasekaran, Suma; Carrillo-Carrasco, Nuria; Senac, Julien S.; Hofherr, Sean E.; Barry, Michael A; Venditti, Charles P.

In: Human Gene Therapy, Vol. 22, No. 4, 01.04.2011, p. 477-481.

Research output: Contribution to journalArticle

Chandler, RJ, Chandrasekaran, S, Carrillo-Carrasco, N, Senac, JS, Hofherr, SE, Barry, MA & Venditti, CP 2011, 'Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia', Human Gene Therapy, vol. 22, no. 4, pp. 477-481. https://doi.org/10.1089/hum.2010.164
Chandler, Randy J. ; Chandrasekaran, Suma ; Carrillo-Carrasco, Nuria ; Senac, Julien S. ; Hofherr, Sean E. ; Barry, Michael A ; Venditti, Charles P. / Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia. In: Human Gene Therapy. 2011 ; Vol. 22, No. 4. pp. 477-481.
@article{33af4cfca86141f2a50b46710d488334,
title = "Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia",
abstract = "Propionic acidemia (PA) is an autosomal recessive disorder of metabolism caused by a deficiency of propionyl-coenzyme A carboxylase (PCC). Despite optimal dietary and cofactor therapy, PA patients still suffer from lethal metabolic instability and experience multisystemic complications. A murine model of PA (Pcca -/-) of animals that uniformly die within the first 48hr of life was used to determine the efficacy of adeno-associated viral (AAV) gene transfer as a potential therapy for PA. An AAV serotype 8 (AAV8) vector was engineered to express the human PCCA cDNA and delivered to newborn mice via an intrahepatic injection. Greater than 64{\%} of the Pcca -/- mice were rescued after AAV8-mediated gene transfer and survived until day of life 16 or beyond. Western analysis of liver extracts showed that PCC was completely absent from Pcca -/- mice but was restored to greater than wild-type levels after AAV gene therapy. The treated Pcca -/- mice also exhibited markedly reduced plasma levels of 2-methylcitrate compared with the untreated Pcca -/- mice, which indicates significant PCC enzymatic activity was provided by gene transfer. At the time of this report, the oldest treated Pcca -/- mice are over 6 months of age. In summary, AAV gene delivery of PCCA effectively rescues Pcca -/- mice from neonatal lethality and substantially ameliorates metabolic markers of the disease. These experiments demonstrate a gene transfer approach using AAV8 that might be used as a treatment for PA, a devastating and often lethal disorder desperately in need of new therapeutic options.",
author = "Chandler, {Randy J.} and Suma Chandrasekaran and Nuria Carrillo-Carrasco and Senac, {Julien S.} and Hofherr, {Sean E.} and Barry, {Michael A} and Venditti, {Charles P.}",
year = "2011",
month = "4",
day = "1",
doi = "10.1089/hum.2010.164",
language = "English (US)",
volume = "22",
pages = "477--481",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia

AU - Chandler, Randy J.

AU - Chandrasekaran, Suma

AU - Carrillo-Carrasco, Nuria

AU - Senac, Julien S.

AU - Hofherr, Sean E.

AU - Barry, Michael A

AU - Venditti, Charles P.

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Propionic acidemia (PA) is an autosomal recessive disorder of metabolism caused by a deficiency of propionyl-coenzyme A carboxylase (PCC). Despite optimal dietary and cofactor therapy, PA patients still suffer from lethal metabolic instability and experience multisystemic complications. A murine model of PA (Pcca -/-) of animals that uniformly die within the first 48hr of life was used to determine the efficacy of adeno-associated viral (AAV) gene transfer as a potential therapy for PA. An AAV serotype 8 (AAV8) vector was engineered to express the human PCCA cDNA and delivered to newborn mice via an intrahepatic injection. Greater than 64% of the Pcca -/- mice were rescued after AAV8-mediated gene transfer and survived until day of life 16 or beyond. Western analysis of liver extracts showed that PCC was completely absent from Pcca -/- mice but was restored to greater than wild-type levels after AAV gene therapy. The treated Pcca -/- mice also exhibited markedly reduced plasma levels of 2-methylcitrate compared with the untreated Pcca -/- mice, which indicates significant PCC enzymatic activity was provided by gene transfer. At the time of this report, the oldest treated Pcca -/- mice are over 6 months of age. In summary, AAV gene delivery of PCCA effectively rescues Pcca -/- mice from neonatal lethality and substantially ameliorates metabolic markers of the disease. These experiments demonstrate a gene transfer approach using AAV8 that might be used as a treatment for PA, a devastating and often lethal disorder desperately in need of new therapeutic options.

AB - Propionic acidemia (PA) is an autosomal recessive disorder of metabolism caused by a deficiency of propionyl-coenzyme A carboxylase (PCC). Despite optimal dietary and cofactor therapy, PA patients still suffer from lethal metabolic instability and experience multisystemic complications. A murine model of PA (Pcca -/-) of animals that uniformly die within the first 48hr of life was used to determine the efficacy of adeno-associated viral (AAV) gene transfer as a potential therapy for PA. An AAV serotype 8 (AAV8) vector was engineered to express the human PCCA cDNA and delivered to newborn mice via an intrahepatic injection. Greater than 64% of the Pcca -/- mice were rescued after AAV8-mediated gene transfer and survived until day of life 16 or beyond. Western analysis of liver extracts showed that PCC was completely absent from Pcca -/- mice but was restored to greater than wild-type levels after AAV gene therapy. The treated Pcca -/- mice also exhibited markedly reduced plasma levels of 2-methylcitrate compared with the untreated Pcca -/- mice, which indicates significant PCC enzymatic activity was provided by gene transfer. At the time of this report, the oldest treated Pcca -/- mice are over 6 months of age. In summary, AAV gene delivery of PCCA effectively rescues Pcca -/- mice from neonatal lethality and substantially ameliorates metabolic markers of the disease. These experiments demonstrate a gene transfer approach using AAV8 that might be used as a treatment for PA, a devastating and often lethal disorder desperately in need of new therapeutic options.

UR - http://www.scopus.com/inward/record.url?scp=79954533921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954533921&partnerID=8YFLogxK

U2 - 10.1089/hum.2010.164

DO - 10.1089/hum.2010.164

M3 - Article

C2 - 20950151

AN - SCOPUS:79954533921

VL - 22

SP - 477

EP - 481

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 4

ER -